0001209191-17-057645.txt : 20171020
0001209191-17-057645.hdr.sgml : 20171020
20171020164558
ACCESSION NUMBER: 0001209191-17-057645
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170818
FILED AS OF DATE: 20171020
DATE AS OF CHANGE: 20171020
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Curran Terrie
CENTRAL INDEX KEY: 0001690298
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37929
FILM NUMBER: 171147403
MAIL ADDRESS:
STREET 1: C/O MYOVANT SCIENCES INC.
STREET 2: 320 WEST 37TH STREET, 5TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10018
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Myovant Sciences Ltd.
CENTRAL INDEX KEY: 0001679082
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: D0
FISCAL YEAR END: 0331
BUSINESS ADDRESS:
STREET 1: 20-22 BEDFORD ROW
CITY: LONDON
STATE: X0
ZIP: WC1R 4JS
BUSINESS PHONE: (441) 824-8101
MAIL ADDRESS:
STREET 1: 20-22 BEDFORD ROW
CITY: LONDON
STATE: X0
ZIP: WC1R 4JS
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2017-08-18
0
0001679082
Myovant Sciences Ltd.
MYOV
0001690298
Curran Terrie
C/O MYOVANT SCIENCES INC.
2000 SIERRA POINT PARKWAY
BRISBANE
CA
94005
1
0
0
0
Stock Option (Right to Buy)
13.14
2017-08-18
4
A
0
22500
0.00
A
2027-08-17
Common Shares
22500
22500
D
100% of the shares underlying the option vest and become exercisable on the earlier of (a) August 18, 2018, and (b) the date that is one day prior to the Issuer's 2018 Annual General Meeting of Shareholders, subject to the Reporting Person providing continuous service to the Issuer on such date.
/s/Matthew Lang
2017-10-20